Literature DB >> 33527979

Clinicopathologic Features of Peripheral T-Cell Lymphoma in Sub-Saharan Africa.

Megan J Fitzpatrick1, Shahin Sayed2, Zahir Moloo2, Mukendi K A Kayembe3, Drucilla J Roberts1, Thu-Anh Pham1, Liqiang Xi4, Mark Raffeld4, Abner Louissaint1, Aliyah R Sohani1.   

Abstract

OBJECTIVES: Peripheral T-cell lymphomas (PTCLs) are heterogeneous, clinically aggressive, and rare. Subtype distribution varies by geographic location; however, data from sub-Saharan Africa (SSA) are lacking. We sought to elucidate clinicopathologic features of PTCL in SSA.
METHODS: We reviewed PTCL consultation cases from three SSA countries. PTCL subtype was determined per 2017 World Health Organization classification. Cases with sufficient material were evaluated by polymerase chain reaction for human T-cell leukemia virus type 1 (HTLV-1) and T-cell receptor γ (TCRG) rearrangement.
RESULTS: Among 32 cases, median age was 45 years and male-to-female ratio was 1.7. Thirty (94%) of 32 cases required additional workup for subclassification. PTCL, not otherwise specified (PTCL-NOS) was the most common subtype (13/32, 41%), followed by PTCL with T-follicular helper phenotype (6/32, 19%) and systemic anaplastic large cell lymphoma (6/32, 19%). Four (16%) of 25 cases were Epstein-Barr virus positive (EBV+) (2/2 extranodal natural killer/T-cell lymphoma, 1/13 PTCL-NOS, and 1/4 angioimmunoblastic T-cell lymphoma with EBV+ immunoblasts). Two (15%) of 13 patients with PTCL-NOS were human immunodeficiency virus positive. No cases with evaluable DNA (0/15) were HTLV-1 positive, and 9 of 10 showed clonal TCRG rearrangements.
CONCLUSIONS: In comparison to Western studies, PTCLs from SSA show similar subtype distribution and male predominance but a younger age at diagnosis. Appropriate diagnosis of PTCL requires extensive ancillary testing not readily available in low-income countries, including much of SSA. © American Society for Clinical Pathology, 2021. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Epstein-Barr virus; Low/middle-income countries; Peripheral T-cell lymphoma; Sub-Saharan Africa

Mesh:

Year:  2021        PMID: 33527979      PMCID: PMC8209619          DOI: 10.1093/ajcp/aqaa201

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  40 in total

1.  Pathology services in developing countries: a challenge.

Authors:  Hallgrímur Benediktsson; John Whitelaw; Indrojit Roy
Journal:  Arch Pathol Lab Med       Date:  2007-11       Impact factor: 5.534

Review 2.  Lymphomas in sub-Saharan Africa--what can we learn and how can we help in improving diagnosis, managing patients and fostering translational research?

Authors:  Kikkeri N Naresh; Martine Raphael; Leona Ayers; Nina Hurwitz; Valeria Calbi; Emily Rogena; Shahin Sayed; Omar Sherman; Hazem A H Ibrahim; Stefano Lazzi; Vasileios Mourmouras; Patricia Rince; Jessie Githanga; Bessie Byakika; Emma Moshi; Muheez Durosinmi; Babatunde J Olasode; Olayiwola A Oluwasola; Effiong E Akang; Yetunde Akenòva; Melissa Adde; Ian Magrath; Lorenzo Leoncini
Journal:  Br J Haematol       Date:  2011-06-28       Impact factor: 6.998

Review 3.  HIV-associated malignancies in sub-Saharan Africa: progress, challenges, and opportunities.

Authors:  Lameck Chinula; Agnes Moses; Satish Gopal
Journal:  Curr Opin HIV AIDS       Date:  2017-01       Impact factor: 4.283

Review 4.  Expansion of cancer care and control in countries of low and middle income: a call to action.

Authors:  Paul Farmer; Julio Frenk; Felicia M Knaul; Lawrence N Shulman; George Alleyne; Lance Armstrong; Rifat Atun; Douglas Blayney; Lincoln Chen; Richard Feachem; Mary Gospodarowicz; Julie Gralow; Sanjay Gupta; Ana Langer; Julian Lob-Levyt; Claire Neal; Anthony Mbewu; Dina Mired; Peter Piot; K Srinath Reddy; Jeffrey D Sachs; Mahmoud Sarhan; John R Seffrin
Journal:  Lancet       Date:  2010-08-13       Impact factor: 79.321

Review 5.  Cutaneous T-cell lymphoma in skin of color.

Authors:  Ginette A Hinds; Peter Heald
Journal:  J Am Acad Dermatol       Date:  2009-03       Impact factor: 11.527

6.  Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification.

Authors:  K J Savage; M Chhanabhai; R D Gascoyne; J M Connors
Journal:  Ann Oncol       Date:  2004-10       Impact factor: 32.976

7.  CD20+ T-cell lymphoma: clinicopathologic analysis of 9 cases and a review of the literature.

Authors:  Aliyah Rahemtullah; Janina A Longtine; Nancy Lee Harris; Michelle Dorn; Artur Zembowicz; Leticia Quintanilla-Fend; Frederic I Preffer; Judith A Ferry
Journal:  Am J Surg Pathol       Date:  2008-11       Impact factor: 6.394

8.  Lymphoma incidence, survival and prevalence 2004-2014: sub-type analyses from the UK's Haematological Malignancy Research Network.

Authors:  A Smith; S Crouch; S Lax; J Li; D Painter; D Howell; R Patmore; A Jack; E Roman
Journal:  Br J Cancer       Date:  2015-03-24       Impact factor: 7.640

9.  Diffuse Large B-Cell Lymphoma in Kenya: MYC, BCL2, and the Cell of Origin.

Authors:  Jonathan Wawire; Shahin Sayed; Zahir Moloo; Aliyah R Sohani
Journal:  J Glob Oncol       Date:  2019-05

10.  T-cell lymphomas in South america and europe.

Authors:  Monica Bellei; Carlos Sergio Chiattone; Stefano Luminari; Emanuela Anna Pesce; Maria Elena Cabrera; Carmino Antonio de Souza; Raul Gabús; Lucia Zoppegno; Lucia Zoppegno; Jorge Milone; Astrid Pavlovsky; Joseph Michael Connors; Francine Mary Foss; Steven Michael Horwitz; Raymond Liang; Silvia Montoto; Stefano Aldo Pileri; Aaron Polliack; Julie Marie Vose; Pier Luigi Zinzani; Emanuele Zucca; Massimo Federico
Journal:  Rev Bras Hematol Hemoter       Date:  2012
View more
  1 in total

1.  Somatostatin receptor 2 is highly sensitive and specific for Epstein-Barr virus-associated nasopharyngeal carcinoma.

Authors:  Kartik Viswanathan; Peter M Sadow
Journal:  Hum Pathol       Date:  2021-08-18       Impact factor: 3.466

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.